CHRISTINA HUSEMANN: Open Payments
NPI 1649832700 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 24 payments from 12 companies in 2025. Trend: 2023 $551 · 2024 $636 · 2025 $563
Food & beverage: $462Education: $101
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $118 |
| Lilly USA, LLC | 4 | $85 |
| Novo Nordisk Inc | 2 | $57 |
| Exact Sciences Corporation | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 3 | $45 |
| SANOFI PASTEUR INC. | 1 | $39 |
| Amgen Inc. | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: MOUNJARO, Veozah, The Cologuard Plus Collection Kit, VOQUEZNA, FLUZONE HIGH-DOSE, OTEZLA, Wegovy, Rybelsus.
Industry payments across MD — which companies pay providers there.
